Global AI in the Medical Writing Market is experiencing significant growth expecting to grow at a CAGR of 16.1% during the forecasted period (2023-2030). The market growth is owing to factors such as the increasing acceptance of machine learning especially AI, the growing need to reduce healthcare expenditures, and increased R&D investments in pharmaceutical companies to optimize their processes and reduce costs. AI-powered medical writing tools and solutions offer the potential to streamline patient care, diagnostic accuracy, drug discovery, and treatment outcomes, leading to increased adoption, increased efficiency, and minimized manual efforts, ultimately leading to cost savings for healthcare organizations and pharmaceutical firms.
Browse the full report description of “Artificial Intelligence (AI) in Medical Writing Market Size, Share & Trends Analysis Report by Type (Clinical Writing, Type Writing, Scientific Writing, and Others), and by End User (Medical Devices, Pharmaceutical, Biotechnology, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/ai-in-medical-writing-market
Key Trends and Recent Developments in AI in the Medical Writing Market
- Big brands across various industries are launching tools and solutions to streamline the medical writing process driving the market growth. For instance, in September 2023, YouTube launched two new initiatives for healthcare content creators namely AI-enabled Aloud, which dubs videos in various languages, and THE-IQ Creator Program, which expands upon the Tackling Health Equity through the Information Quality program.
- To streamline the regulatory documentation process across the medical industry, different innovations and solutions are entering the market. For instance, in August 2023, TrialAssure, a leading software-as-a-service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, collaborated with MMS, a global clinical research organization, on a new artificial intelligence (AI) initiative aimed at developing generative text specifically for medical writing in the field of drug development.
- To improve the scientific communication and publication process of medical research work, different brands are collaborating to bring AI into medical writing driving the market growth. For instance, in January 2024, Cactus Communications and Taylor & Francis pioneered collaborative AI solutions for medical scholarly publishing. The tool is known as Paperpal Preflight for Editorial Desk and helps bring innovative AI tools to revolutionize editorial workflows.
- Global brands are investing in AI in the medical writing market to bring innovation to upgrade and streamline the medical writing process. For instance, in September 2023, Accenture made a strategic investment, through Accenture Ventures, in Writer, a platform using generative AI to help enterprises create and shape content in the ways people already work.
- Global healthcare organizations and regulatory bodies are encouraging the usage of ethical AI to create and promote medical writing. For instance, in February 2024, The World Health Organization (WHO) released a report focused on exploring guiding principles for developmentally appropriate online mental health content for young people. In the report WHO and NAM encouraged digital platforms to apply global principles and AI tools and solutions for identifying credible sources of health information.
The global AI in the Medical Writing Market is at the beginning stage and has a lot of potential to grow. Some of the major players in the global AI in medical writing market include Trilogy Writing & Consulting GmbH, Cactus Communications, Certara's, Freyr, GENINVO, Indegene, Jasper.ai, Morula health, Parexel International Corporation, Symbiance AI Inc., Turacoz, Webicina Kft., and Yseop S.A.S., among others.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ai-in-medical-writing-market